The DOI matches its Crossref record; 324 of the 324 references it cites were found in a registry or an index.
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
Open accessAbstract
SUMMARY: Within the past 10 years, treatment and diagnostic guidelines for nontuberculous mycobacteria have been recommended by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA). Moreover, the Clinical and Laboratory Standards Institute (CLSI) has published and recently (in 2011) updated recommendations including suggested antimicrobial and susceptibility breakpoints. The CLSI has also recommended the broth microdilution method as the gold standard for laboratories performing antimicrobial susceptibility testing of nontuberculous mycobacteria. This article reviews the laboratory, diagnostic, and treatment guidelines together with established and probable drug resistance mechanisms of the nontuberculous mycobacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationChopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00286-0 · Cited by 1,556 · cited 1×
“However, evidence suggests that rifampin (and presumably the other rifamycins) binds to the DNA/RNA channel (63, 196) rather than in the catalytic center of the -subunit.”
BackgroundinhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389 · cited 2×
“More recently, the primary target of activated isoniazid was identified as one of the fatty acid synthesis II (FAS II) enzymes, enoyl-acyl carrier protein (ACP) reductase, or InhA (20, 197, 203).”
BackgroundDetection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Self-citationMolecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028 · cited 2×
“Vancomycin binds to the D-alanine–D-alanine terminal amino acids of the peptide side chains of peptidoglycan and in doing so prevents the 4-3 cross-linking by the PBP D,L-transpeptidase and other processes in the final assembly of mature peptidoglycan (83).”
BackgroundUpdate on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Nontuberculous mycobacteria and associated diseases.
Oatway, J. W. H. (1979) · PubMed · doi:10.1164/arrd.1979.120.6.1389 · Cited by 992
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950 · cited 1×
“Although tetracycline appears to be able to interact with the ribosome at multiple points, the highest-affinity binding sites are consistent with the interference of the A site (11, 47, 292).”
BackgroundBrown-Elliott, B. A., & Wallace, R. J. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.716-746.2002 · Cited by 909
Self-citationNomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2823 · Cited by 874
The Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
Nash, K. A., Brown-Elliott, B. A., & Wallace, R. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-08 · Cited by 638
Self-citationNontuberculous Mycobacteria: I: Multicenter Prevalence Study in Cystic Fibrosis
Olivier, K. N., Weber, D. J., Wallace, R. J., Faiz, A. R., Lee, J.-H., Zhang, Y., Brown-Elliot, B. A., Handler, A., Wilson, R. W., Schechter, M. S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-678oc · Cited by 631
Self-citationSpectrum of Disease Due to Rapidly Growing Mycobacteria
Wallace, R. J., Swenson, J. M., Silcox, V. A., Good, R. C., Tschen, J. A., & Stone, M. S. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.4.657 · Cited by 584
Self-citationImpact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s
Tortoli, E. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.319-354.2003 · Cited by 574
The Structures of Four Macrolide Antibiotics Bound to the Large Ribosomal Subunit
Hansen, J. L., Ippolito, J. A., Ban, N., Nissen, P., Moore, P. B., & Steitz, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00570-1 · Cited by 568
Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3
Pioletti, M., Schlünzen, F., Harms, J., Zarivach, R., Glühmann, M., Avila, H., Bashan, A., Bartels, H., Auerbach, T., Jacobi, C., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1829 · Cited by 527
Trimethoprim and sulfonamide resistance.
Huovinen, P., Sundström, L., Swedberg, G., & Sköld, O. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.279 · Cited by 523 · cited 2×
“However, the horizontal transfer of resistant alleles accounts for the acquisition of sulfonamide and trimethoprim resistances in many normally susceptible pathogens (169, 353, 354).”
BackgroundGriffith, D. E., Girard, W. M., & Wallace, R. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1271 · Cited by 518
Self-citationClinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
Koh, W.-J., Jeon, K., Lee, N. Y., Kim, B.-J., Kook, Y.-H., Lee, S.-H., Park, Y. K., Kim, C. K., Shin, S. J., Huitt, G. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0395oc · Cited by 515
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Hugonnet, J.-E., Tremblay, L. W., Boshoff, H. I., Barry, C. E., & Blanchard, J. S. (2009) · Science · doi:10.1126/science.1167498 · Cited by 494
The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol
Telenti, A., Philipp, W. J., Sreevatsan, S., Bernasconi, C., Stockbauer, K. E., Wieles, B., Musser, J. M., & Jacobs, W. R. (1997) · Nature Medicine · doi:10.1038/nm0597-567 · Cited by 472
Belanger, A. E., Besra, G. S., Ford, M. E., Mikusová, K., Belisle, J. T., Brennan, P. J., & Inamine, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11919 · Cited by 466
Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
Poole, K. (2001) · PubMed · Cited by 456
Horsburgh, C. R., & Selik, R. M. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.1.4 · Cited by 456
Pulmonary Nontuberculous Mycobacterial Disease: Prospective Study of a Distinct Preexisting Syndrome
Kim, R. D., Greenberg, D. E., Ehrmantraut, M. E., Guide, S. V., Ding, L., Shea, Y., Brown, M. R., Chernick, M., Steagall, W. K., Glasgow, C. G., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-686oc · Cited by 444
Oxazolidinones: activity, mode of action, and mechanism of resistance
Bozdogan, B., & Appelbaum, P. C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.11.003 · Cited by 403
A Structural Model of Transcription Elongation
Korzheva, N., Mustaev, A., Kozlov, M., Malhotra, A., Nikiforov, V., Goldfarb, A., & Darst, S. A. (2000) · Science · doi:10.1126/science.289.5479.619 · Cited by 402
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Resistance to trimethoprim and sulfonamides
Sk�ld, O. (2001) · Veterinary Research · doi:10.1051/vetres:2001123 · Cited by 384
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Heym, B., Philipp, W., & Cole, S. T. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80166-2_3 · Cited by 379
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Nontuberculous mycobacteria and associated diseases.
Wolinsky, E. (1979) · PubMed · doi:10.1164/arrd.1979.119.1.107 · Cited by 367
Wallace, R. J., Brown, B. A., & Onyi, G. O. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.2.405 · Cited by 361
Self-citationFinken, M., Kirschner, P., Meier, A., Wrede, A., & Böttger, E. C. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01253.x · Cited by 360
Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease
Griffith, D. E., Brown-Elliott, B. A., Langsjoen, B., Zhang, Y., Pan, X., Girard, W., Nelson, K., Caccitolo, J., Alvarez, J., Shepherd, S., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-450oc · Cited by 357
Self-citationLavollay, M., Arthur, M., Fourgeaud, M., Dubost, L., Marie, A., Veziris, N., Blanot, D., Gutmann, L., & Mainardi, J.-L. (2008) · Journal of Bacteriology · doi:10.1128/jb.00239-08 · Cited by 349
Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338
Jeon, K., Kwon, O. J., Lee, N. Y., Kim, B.-J., Kook, Y.-H., Lee, S.-H., Park, Y. K., Kim, C. K., & Koh, W.-J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0704oc · Cited by 336
Bastian, S., Veziris, N., Roux, A.-L., Brossier, F., Gaillard, J.-L., Jarlier, V., & Cambau, E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00861-10 · Cited by 333
Prevalence and Economic Burden of Bronchiectasis
Weycker, D., Edelsberg, J., Oster, G., & Tino, G. (2005) · Clinical Pulmonary Medicine · doi:10.1097/01.cpm.0000171422.98696.ed · Cited by 327
Modulation of RNA function by aminoglycoside antibiotics
Schroeder, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.1 · Cited by 325
Infection Control in Cystic Fibrosis
Saiman, L., & Siegel, J. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.57-71.2004 · Cited by 324
Roux, A.-L., Catherinot, E., Ripoll, F., Soismier, N., Macheras, E., Ravilly, S., Bellis, G., Vibet, M.-A., Le Roux, E., Lemonnier, L., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01257-09 · Cited by 322
Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy
Winthrop, K. L., Chang, E., Yamashita, S., Iademarco, M. F., & LoBue, P. A. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1510.090310 · Cited by 320
Wilson, D. N., Schluenzen, F., Harms, J. M., Starosta, A. L., Connell, S. R., & Fucini, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804276105 · Cited by 318
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-855oc · Cited by 318
Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Shafran, S. D., Singer, J., Zarowny, D. P., Phillips, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, M. J., Rachlis, A. R., Lalonde, R. G., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350602 · Cited by 307
Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit
Ippolito, J. A., Kanyo, Z. F., Wang, D., Franceschi, F. J., Moore, P. B., Steitz, T. A., & Duffy, E. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800379d · Cited by 303
Brown, B. A., Wallace, R. J., Onyi, G. O., De Rosas, V, & Wallace, R. J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.180 · Cited by 301
Self-citationBiogenesis of the mycobacterial cell wall and the site of action of ethambutol
Mikusová, K., Slayden, R. A., Besra, G. S., & Brennan, P. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2484 · Cited by 301
Adékambi, T., Reynaud-Gaubert, M., Greub, G., Gevaudan, M.-J., La Scola, B., Raoult, D., & Drancourt, M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5493-5501.2004 · Cited by 299
Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis
Crick, D. C., Mahapatra, S., & Brennan, P. J. (2001) · Glycobiology · doi:10.1093/glycob/11.9.107r · Cited by 293
HORSBURGH, C. R., MASON, U. G., FARHI, D. C., & ISEMAN, M. D. (1985) · Medicine · doi:10.1097/00005792-198501000-00003 · Cited by 293
Molecular Genetics of Mycobacteria
Arora, V. K. (2015) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2015.04.014 · Cited by 288
Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections
Thomson, R. M., on behalf of the NTM working group at the Queensland TB Control Centre, & Laboratory, Q. M. R. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1610.091201 · Cited by 283
Wallace, R. J., Meier, A., Brown, B. A., Zhang, Y., Sander, P., Onyi, G. O., & Böttger, E. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1676 · Cited by 283
Self-citationClinical features of disease caused by rapidly growing mycobacteria
De, G. (1993) · Medical Entomology and Zoology · Cited by 279
Wallace, R. J., Swenson, J. M., Silcox, V. A., & Bullen, M. G. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/152.3.500 · Cited by 272
Self-citationMechanisms of Drug Resistance in Mycobacterium tuberculosis
Zhang, Y., Vilchèze, C., & Jacobs, W. R. (2004) · Tuberculosis and the Tubercle Bacillus · doi:10.1128/9781555817657.ch8 · Cited by 261
Increasing Incidence of Nontuberculous Mycobacteria, Taiwan, 2000–2008
Lai, C.-C., Tan, C.-K., Chou, C.-H., Hsu, H.-L., Liao, C.-H., Huang, Y.-T., Yang, P.-C., Luh, K.-T., & Hsueh, P.-R. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1602.090675 · Cited by 261
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
Wallace, R. J., Brown, B. A., Griffith, D. E., Girard, W. M., & Murphy, D. T. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665032 · Cited by 258
Self-citationAntimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae
Swenson, J. M., Wallace, R. J., Silcox, V. A., & Thornsberry, C. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.6.807 · Cited by 258
Self-citationDisseminated "Mycobacterium genavense" infection in patients with AIDS
Bottger, E. C., Teske, A., Kirschner, P., Bost, S., Hirschel, B., Chang, H. R., & Beer, V. (1992) · The Lancet · doi:10.1016/0140-6736(92)90397-l · Cited by 250
Meka, V. G., Pillai, S. K., Sakoulas, G., Wennersten, C., Venkataraman, L., DeGirolami, P. C., Eliopoulos, G. M., Moellering, Jr., & Gold, H. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/421471 · Cited by 247
Wallace, R. J., Tanner, D., Brennan, P. J., & Brown, B. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-6-199309150-00006 · Cited by 241
Self-citationPrammananan, T., Sander, P., Brown, B. A., Frischkorn, K., Onyi, G. O., Zhang, Y., Böttger, E. C., & Wallace, Jr. (1998) · The Journal of Infectious Diseases · doi:10.1086/515328 · Cited by 241
Ramaswamy, S. V., Amin, A. G., Göksel, S., Stager, C. E., Dou, S.-J., El Sahly, H., Moghazeh, S. L., Kreiswirth, B. N., & Musser, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.326-336.2000 · Cited by 240
Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis
Li, X.-Z., Zhang, L., & Nikaido, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2415-2423.2004 · Cited by 239
Williams, D. L., Spring, L., Collins, L., Miller, L. P., Heifets, L. B., Gangadharam, P. R. J., & Gillis, T. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1853 · Cited by 236
DNA and RNA Synthesis: Antifolates
Kompis, I. M., Islam, K., & Then, R. L. (2005) · Chemical Reviews · doi:10.1021/cr0301144 · Cited by 231
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
Schlünzen, F., Harms, J. M., Franceschi, F., Hansen, H. A. S., Bartels, H., Zarivach, R., & Yonath, A. (2003) · Structure · doi:10.1016/s0969-2126(03)00022-4 · Cited by 231
Mycobacterium avium in the Postgenomic Era
Turenne, C. Y., Wallace, R., & Behr, M. A. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-06 · Cited by 226
Self-citationActivities of Linezolid against Rapidly Growing Mycobacteria
Wallace, R. J., Brown-Elliott, B. A., Ward, S. C., Crist, C. J., Mann, L. B., & Wilson, R. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.764-767.2001 · Cited by 226
Self-citationUslan, D. Z., Kowalski, T. J., Wengenack, N. L., Virk, A., & Wilson, J. W. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.10.1287 · Cited by 223
Molecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis
Jönsson, B. E., Gilljam, M., Lindblad, A., Ridell, M., Wold, A. E., & Welinder-Olsson, C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02592-06 · Cited by 222
Irreversible Inhibition of the Mycobacterium tuberculosis β-Lactamase by Clavulanate
Hugonnet, J.-E., & Blanchard, J. S. (2007) · Biochemistry · doi:10.1021/bi701506h · Cited by 220
Defects in the interferon‐γ and interleukin‐12 pathways
Rosenzweig, S. D., & Holland, S. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00227.x · Cited by 219
Tigecycline Is Modified by the Flavin-Dependent Monooxygenase TetX
Moore, I. F., Hughes, D. W., & Wright, G. D. (2005) · Biochemistry · doi:10.1021/bi0506066 · Cited by 217
Flores, A. R., Parsons, L. M., & Pavelka (2005) · Microbiology · doi:10.1099/mic.0.27629-0 · Cited by 217
Sanguinetti, M., Ardito, F., Fiscarelli, E., La Sorda, M., D'Argenio, P., Ricciotti, G., & Fadda, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.2.816-819.2001 · Cited by 210
Wilson, R. W., Steingrube, V. A., Böttger, E. C., Springer, B., Brown-Elliott, B. A., Vincent, V, Jost, K. C., Zhang, Y., Garcia, M. J., Chiu, S. H., et al. (2001) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-51-5-1751 · Cited by 210
Self-citationKim, H.-Y., Kim, B. J., Kook, Y., Yun, Y.-J., Shin, J. H., Kim, B.-J., & Kook, Y.-H. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00221.x · Cited by 209
Springer, B., Kidan, Y. G., Prammananan, T., Ellrott, K., Böttger, E. C., & Sander, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2877-2884.2001 · Cited by 208
Functional, biophysical, and structural bases for antibacterial activity of tigecycline
Olson, M. W., Ruzin, A., Feyfant, E., Rush, T. S., O'Connell, J., & Bradford, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01499-05 · Cited by 207
Locke, J. B., Hilgers, M., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-09 · Cited by 205
Brown, B. A., Springer, B., Steingrube, V. A., Wilson, R. W., Pfyffer, G. E., Garcia, M. J., Menendez, M. C., Rodriguez-Salgado, B., Jost, K. C., Chiu, S. H., et al. (1999) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-49-4-1493 · Cited by 204
Self-citationJernigan, J. A., & Farr, B. M. (2000) · Clinical Infectious Diseases · doi:10.1086/313972 · Cited by 204
Larsen, M. H., Vilchèze, C., Kremer, L., Besra, G. S., Parsons, L., Salfinger, M., Heifets, L., Hazbon, M. H., Alland, D., Sacchettini, J. C., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03162.x · Cited by 202
Pulmonary Illness Associated With Exposure to Mycobacterium-avium Complex in Hot Tub Water
Embil, J., Warren, P., Yakrus, M., Stark, R., Corne, S., Forrest, D., & Hershfield, E. (1997) · Chest · doi:10.1378/chest.111.3.813 · Cited by 202
Nontuberculous Mycobacteria: II: Nested-Cohort Study of Impact on Cystic Fibrosis Lung Disease
Olivier, K. N., Weber, D. J., Lee, J.-H., Handler, A., Tudor, G., Molina, P. L., Tomashefski, J., & Knowles, M. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-679oc · Cited by 201
Levy, I., Grisaru-Soen, G., Lerner-Geva, L., Kerem, E., Blau, H., Bentur, L., Aviram, M., Rivlin, J., Picard, E., Lavy, A., et al. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1403.061405 · Cited by 201
Takiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B., Salazar, L., Bloom, B. R., & Jacobs, W. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.362 · Cited by 198
Meier, A., Kirschner, P., Springer, B., Steingrube, V. A., Brown, B. A., Wallace, R. J., & Böttger, E. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.381 · Cited by 195
Self-citation16S rRNA Mutation Associated with Tetracycline Resistance in a Gram-Positive Bacterium
Ross, J. I., Eady, E. A., Cove, J. H., & Cunliffe, W. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1702 · Cited by 194
Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr
Baysarowich, J., Koteva, K., Hughes, D. W., Ejim, L., Griffiths, E., Zhang, K., Junop, M., & Wright, G. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711939105 · Cited by 194
Aínsa, J. A., Blokpoel, M. C. J., Otal, I., Young, D. B., De Smet, K. A. L., & Martín, C. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.22.5836-5843.1998 · Cited by 189
Factors Related to Response to Intermittent Treatment of Mycobacterium avium Complex Lung Disease
Lam, P. K., Griffith, D. E., Aksamit, T. R., Ruoss, S. J., Garay, S. M., Daley, C. L., & Catanzaro, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1531oc · Cited by 187
Takayama, K., Schnoes, H. K., Armstrong, E. L., & Boyle, R. W. (1975) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36719-5 · Cited by 185
Ketolides lack inducibility properties of MLS(B) resistance phenotype
Bonnefoy, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.85 · Cited by 183
The Ketolides: A Critical Review
Zhanel, G. G., Walters, M., Noreddin, A., Vercaigne, L. M., Wierzbowski, A., Embil, J. M., Gin, A. S., Douthwaite, S., & Hoban, D. J. (2002) · Drugs · doi:10.2165/00003495-200262120-00006 · Cited by 183
Novel Mechanism of β-Lactam Resistance Due to Bypass of DD-Transpeptidation in Enterococcus faecium
Mainardi, J., Legrand, R., Arthur, M., Schoot, B. M., van HEIJENOORT, J., & Gutmann, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909877199 · Cited by 182
Lewis, F. M. T., Marsh, B. J., & von Reyn, C. F. (2003) · Clinical Infectious Diseases · doi:10.1086/376628 · Cited by 181
Disseminated Infection with Rapidly Growing Mycobacteria
Ingram, C. W., Tanner, D. C., Durack, D. T., Kernodle, G. W., & Corey, G. R. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.4.463 · Cited by 179
Primm, T. P., & Falkinham, J. O. (2014) · Reference Module in Biomedical Sciences · doi:10.1016/b978-0-12-801238-3.03009-9 · Cited by 178
Epidemiology, etiology, and prevention of lung cancer
Bilello, K. S., Murin, S., & Matthay, R. A. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00057-1 · Cited by 175
Saubolle, M. A., Kiehn, T. E., White, M. H., Rudinsky, M. F., & Armstrong, D. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.435 · Cited by 174
Role of embB in natural and acquired resistance to ethambutol in mycobacteria
Alcaide, F., Pfyffer, G. E., & Telenti, A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2270 · Cited by 172
The Mycobacterial Cell Envelope
(2008) · ASM Press eBooks · doi:10.1128/9781555815783 · Cited by 169
Mycobacterium abscessus and Children with Cystic Fibrosis
Sermet-Gaudelus, I., Le Bourgeois, M., Pierre-Audigier, C., Offredo, C., Guillemot, D., Halley, S., Akoua-Koffi, C., Vincent, V., Sivadon-Tardy, V., Ferroni, A., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0912.020774 · Cited by 169
Besier, S. M., Ludwig, A., Zander, J., Brade, V., & Wichelhaus, T. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01098-07 · Cited by 169
Mycobacterium abscessus Infection in Cystic Fibrosis: Colonization or Infection?
CULLEN, A. R., CANNON, C. L., MARK, E. J., & COLIN, A. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9903062 · Cited by 168
Tanaka, E., Amitani, R., Niimi, A., Suzuki, K., Murayama, T., & Kuze, F. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.6.9196113 · Cited by 168
Nontuberculous Mycobacteria in Adult Patients with Cystic Fibrosis
Kilby, J. M., Gilligan, P. H., Yankaskas, J. R., Highsmith, W. E., Edwards, L. J., & Knowles, M. R. (1992) · Chest · doi:10.1378/chest.102.1.70 · Cited by 167
Wolter, N., Smith, A. M., Farrell, D. J., Schaffner, W., Moore, M. R., Whitney, C. G., Jorgensen, J. H., & Klugman, K. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3554-3557.2005 · Cited by 165
Kobashi, Y., Matsushima, T., & Oka, M. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2006.04.002 · Cited by 164
Locke, J. B., Finn, J., Hilgers, M. T., Morales, G., Rahawi, S., Kedar, G. C., Picazo, J. J., Im, W., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-10 · Cited by 164
Pierre-Audigier, C., Ferroni, A., Sermet-Gaudelus, I., Le Bourgeois, M., Offredo, C., Vu-Thien, H., Fauroux, B., Mariani, P., Munck, A., Bingen, E., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3467-3470.2005 · Cited by 164
Band, J. D., Ward, J. I., Fraser, D. W., Peterson, N. J., Silcox, V. A., Good, R. C., Ostroy, P. R., & Kennedy, J. (1982) · Journal of Infectious Diseases · doi:10.1093/infdis/145.1.9 · Cited by 163
Bauer, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh125 · Cited by 163
Nair, J., Rouse, D. A., Bai, G., & Morris, S. L. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00924.x · Cited by 163
Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase
Piton, J., Petrella, S., Delarue, M. H., André-Leroux, G., Jarlier, V., Aubry, A., & Mayer, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012245 · Cited by 161
Polyclonal Mycobacterium avium Complex Infections in Patients with Nodular Bronchiectasis
WALLACE, R. J., ZHANG, Y., BROWN, B. A., DAWSON, D., MURPHY, D. T., WILSON, R., & GRIFFITH, D. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.4.9712098 · Cited by 161
Self-citationGriffith, D. E., Brown, B. A., Girard, W. M., & Wallace, R. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.3.594 · Cited by 159
Self-citationDisease in children due to mycobacteria other than Mycobacterium tuberculosis.
Lincoln, E. M., & Gilbert, L. A. (1972) · PubMed · doi:10.1164/arrd.1972.105.5.683 · Cited by 158
Rodrigues, L., Ramos, J., Couto, I., Amaral, L., & Viveiros, M. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-35 · Cited by 158
Bergeron, J., Ammirati, M., Danley, D., James, L., Norcia, M., Retsema, J., Strick, C. A., Su, W. G., Sutcliffe, J., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2226 · Cited by 157
Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope
Deng, L. L., Mikušová, K., Robuck, K. G., Scherman, M., Brennan, P. J., & McNeil, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.694 · Cited by 157
Hypersensitivity Pneumonitis Reaction to Mycobacterium avium in Household Water
Marras, T. K., Wallace, R. J., Koth, L. L., Stulbarg, M. S., Cowl, C. T., & Daley, C. L. (2005) · CHEST Journal · doi:10.1378/chest.127.2.664 · Cited by 155
Self-citationSlayden, R. A., Lee, R. E., Jr., & Barry, C. E. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02145.x · Cited by 153
Research Committee of the British Thoracic Society (2001) · Thorax · doi:10.1136/thorax.56.3.167 · Cited by 153
Liu, J., Takiff, H. E., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.13.3791-3795.1996 · Cited by 151
Eid, A. J., Berbari, E. F., Sia, I. G., Wengenack, N. L., Osmon, D. R., & Razonable, R. R. (2007) · Clinical Infectious Diseases · doi:10.1086/520982 · Cited by 151
Garza‐Ramos, G., Xiong, L., Zhong, P., & Mankin, A. S. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6898-6907.2001 · Cited by 149
Yang, B., Koga, H., Ohno, H., Ogawa, K., Fukuda, M., Hirakata, Y., Maesaki, S., Tomono, K., Tashiro, T., & Kohno, S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.621 · Cited by 148
Catheter-Related Infections Caused by the Mycobacterium fortuitum Complex: 15 Cases and Review
RAAD, I. I., Vartivarian, S. E., Khan, A., & Bodey, G. P. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.6.1120 · Cited by 147
An outbreak of Mycobacterium chelonae infection after LASIK
de Freitas, D., Alvarenga, L. S., Sampaio, J. L. M., Mannis, M. J., Sato, É. H., de Sousa, L. B., Vieira, L., Yu, M. C. Z., Martins, M. C., Höffling-Lima, A. L., et al. (2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01643-3 · Cited by 147
Billinger, M. E., Olivier, K. N., Viboud, C. G., de Oca, R. M., Steiner, C., Holland, S. M., & Prevots, D. R. (2009) · Emerging infectious diseases · doi:10.3201/eid1510.090196 · Cited by 146
Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum
Nash, K. A., Zhang, Y., Brown‐Elliott, B. A., & Wallace, R. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh523 · Cited by 144
Self-citationGordin, F. M., Sullam, P. M., Shafran, S. D., Cohn, D. L., Wynne, B. A., Paxton, L., Perry, K., & Horsburgh, C. R. (1999) · Clinical Infectious Diseases · doi:10.1086/514748 · Cited by 144
The isolation of M. kansasii and M. xenopi from water systems
McSwiggan, D. A., & Collins, C. H. (1974) · Tubercle · doi:10.1016/0041-3879(74)90038-5 · Cited by 141
Lee, R. E., Jr., Mikušová, K., Brennan, P. J., & Besra, G. S. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00153a002 · Cited by 140
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Cole, S. T. (1994) · Immunobiology · doi:10.1016/s0171-2985(11)80466-3 · Cited by 140
The Peptidoglycan of Mycobacterium abscessus Is Predominantly Cross-Linked by l , d -Transpeptidases
Lavollay, M., Fourgeaud, M., Herrmann, J., Dubost, L., Marie, A., Gutmann, L., Arthur, M., & Mainardi, J. (2010) · Journal of Bacteriology · doi:10.1128/jb.00606-10 · Cited by 140
Nash, K. A., & Inderlied, C. B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2625 · Cited by 139
Self-citationMultidrug Resistance of a Porin Deletion Mutant of Mycobacterium smegmatis
Stephan, J., Mailaender, C., Etienne, G., Daffé, M., & Niederweis, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4163-4170.2004 · Cited by 139
Arias, C. A., Vallejo, M., Reyes, J., Panesso, D., Moreno, J., Castañeda, E., Villegas, M. V., Murray, B. E., & Quinn, J. P. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01886-07 · Cited by 135
Quan, S., Venter, H., & Dabbs, E. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2456 · Cited by 135
Role of Porins for Uptake of Antibiotics by Mycobacterium smegmatis
Danilchanka, O., Pavlenok, M., & Niederweis, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00239-08 · Cited by 135
First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosis
Richter, E., Rüsch–Gerdes, S., & Hillemann, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-06 · Cited by 133
Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid
Argyrou, A., Vetting, M. W., Aladegbami, B. G., & Blanchard, J. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1089 · Cited by 131
Mycobacterium malmoense sp. nov.
SCHRODER, K. H., & Juhlin, I. (1977) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-27-3-241 · Cited by 128
Schinsky, M. F., Morey, R. E., Steigerwalt, A. G., Douglas, M. P., Wilson, R. W., Floyd, M. M., Butler, W. R., Daneshvar, M. I., Brown‐Elliott, B. A., Wallace, R. J., et al. (2004) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.02743-0 · Cited by 128
Self-citationZiedalski, T. M., Kao, P. N., Henig, N. R., Jacobs, S. S., & Ruoss, S. J. (2006) · CHEST Journal · doi:10.1378/chest.130.4.995 · Cited by 126
Ethambutol Ocular Toxicity in Treatment Regimens for Mycobacterium avium Complex Lung Disease
Griffith, D. E., Brown‐Elliott, B. A., Shepherd, S., McLarty, J. W., Griffith, L., & Wallace, R. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-863oc · Cited by 126
Self-citationMahapatra, S., Scherman, H., Brennan, P. J., & Crick, D. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2341-2347.2005 · Cited by 125
Intrinsic Macrolide Resistance in Rapidly Growing Mycobacteria
Nash, K. A., Andini, N., Zhang, Y., Brown‐Elliott, B. A., & Wallace, R. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-06 · Cited by 124
Self-citationBrown, B. A., Wallace, R. J., & Onyi, G. O. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1987 · Cited by 124
Self-citationPreclinical Pharmacology of GAR‐936, a Novel Glycylcycline Antibacterial Agent
Projan, S. J. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.14.219s.35046 · Cited by 123
Dalovisio, J. R., Pankey, G. A., Wallace, R. J., & Jones, D. B. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.5.1068 · Cited by 122
Self-citationMycobacterial lung disease in cystic fibrosis: a prospective study
Fauroux, B., Delaisi, B., Clément, A., Saizou, C., Moissenet, D., Truffot-Pernot, C., Tournier, G., & Vu-Thien, H. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199704000-00004 · Cited by 122
Wallace, R. J., Dalovisio, J. R., & Pankey, G. A. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.5.611 · Cited by 120
Self-citationDrug intolerance to high-dose clarithromycin among elderly patients
Wallace, R. J., Brown, B. A., & Griffith, D. E. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90112-k · Cited by 119
Self-citationCluster of Mycobacterium Chelonae keratitis cases following laser in-situ keratomileusis
Chandra, N. S., Torres, M. F., Winthrop, K. L., Bruckner, D. A., Heidemann, D. G., Calvet, H. M., Yakrus, M. A., Mondino, B. J., & Holland, G. N. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01267-3 · Cited by 117
Permeability Barrier to Rifampin in Mycobacteria
Hui, J., Gordon, N. C., & Kajioka, R. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.773 · Cited by 117
Meier, A., Heifets, L. B., Wallace, R. J., Zhang, Y., Brown, B. A., Sander, P., & Böttger, E. C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.354 · Cited by 117
Self-citationGriffith, D. E., Brown, B. A., Cegielski, P., Murphy, D. T., & Wallace, R. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313644 · Cited by 116
Self-citationSlayden, R. A., & Barry, C. E. (2002) · Tuberculosis · doi:10.1054/tube.2002.0333 · Cited by 115
Rifampin-Resistant Mycobacterium kansasii
Wallace, R. J., Dunbar, D., Brown, B. A., Onyi, G. O., Dunlap, R., Ahn, C. H., & Murphy, D. T. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.5.736 · Cited by 115
Self-citationTebas, P., Sultan, F., Wallace, R. J., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.2.443 · Cited by 114
Self-citationNontuberculous mycobacterial lung disease
Griffith, D. E. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328336ead6 · Cited by 113
Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease
Griffith, D. E., Brown, B. A., Girard, W. M., Griffith, B. E., Couch, L., & Wallace, R. J. (2001) · Clinical Infectious Diseases · doi:10.1086/320512 · Cited by 113
Self-citationSalah, I. B., Cayrou, C., Raoult, D., & Drancourt, M. (2009) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.010637-0 · Cited by 112
The growth rate of Mycobacterium smegmatis depends on sufficient porin‐mediated influx of nutrients
Stephan, J., Bender, J. K., Wolschendorf, F., Hoffmann, C., Roth, E., Mailänder, C., Engelhardt, H., & Niederweis, M. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04878.x · Cited by 112
Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis
Whittier, S., Hopfer, R. L., Knowles, M. R., & Gilligan, P. H. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.861-864.1993 · Cited by 111
Wallace, R. J., Zhang, Y., Brown‐Elliott, B. A., Yakrus, M. A., Wilson, R. W., Mann, L. B., Couch, L., Girard, W. M., & Griffith, D. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341207 · Cited by 111
Self-citationIsoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis
Viveiros, M., Portugal, I., Bettencourt, R., Victor, T. C., Jordaan, A. M., Leandro, C., Ordway, D. J., & Amaral, L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2804-2810.2002 · Cited by 110
Tetracycline resistance determinants in Mycobacterium and Streptomyces species
Pang, Y., Brown, B. A., STEINGRUBE, V. A., Wallace, R. J., & Roberts, M. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1408 · Cited by 109
Self-citationPiddock, L. J. V., Williams, K. J., & Ricci, V. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.2.159 · Cited by 109
Владиславович, М. И., Otten, T., Vyshnevskiy, B. I., & Narvskaya, O. V. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3810-3813.2002 · Cited by 109
Activity of the Ketolide Telithromycin Is Refractory to Erm Monomethylation of Bacterial rRNA
Liu, M., & Douthwaite, S. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1629-1633.2002 · Cited by 108
Griffith, D. E., Brown‐Elliott, B. A., & Wallace, R. J. (2003) · Clinical Infectious Diseases · doi:10.1086/378742 · Cited by 108
Self-citationWallace, R. J., Silcox, V. A., Tsukamura, M., Brown, B. A., Kilburn, J. O., Butler, W. R., & Onyi, G. O. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.12.3231-3239.1993 · Cited by 107
Self-citationCooksey, R. C., Morlock, G. P., McQueen, A., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1186 · Cited by 107
In Vitro Activity of Linezolid against Slowly Growing Nontuberculous Mycobacteria
Brown‐Elliott, B. A., Crist, C. J., Mann, L. B., Wilson, R. W., & Wallace, R. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1736-1738.2003 · Cited by 106
Self-citationChetchotisakd, P., Mootsikapun, P., Anunnatsiri, S., Jirarattanapochai, K., Choonhakarn, C., Chaiprasert, A., Ubol, P. N., Wheat, L. J., & Davis, T. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313589 · Cited by 106
FLENSBURG, J., & SKÖLD, O. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb10664.x · Cited by 103
Levin, M. E., & Hatfull, G. F. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01572.x · Cited by 103
Wallace, R. J., Brown, B. A., & Onyi, G. O. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.4.773 · Cited by 102
Self-citationSander, P., Belova, L., Kidan, Y. G., Pfister, P., Mankin, A. S., & Böttger, E. C. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03242.x · Cited by 102
Increasing Incidence of Nontuberculous Mycobacteria
Lai, C., Tan, C., Chou, C., Hsu, H., Liao, C., Huang, Y., Yang, P., Luh, K., & Hsueh, P. (2010) · Cited by 102
Kobashi, Y., Yoshida, K., Miyashita, N., Niki, Y., & Oka, M. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0457-8 · Cited by 101
Jarlier, V., Gutmann, L., & Nikaido, H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1937 · Cited by 101
Cited by
Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00535-2020 · Cited by 924
Self-citationDaley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa241 · Cited by 890
Self-citationDaley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1125 · Cited by 786
Self-citationGriffith, D. E., Eagle, G., Thomson, R., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O’Donnell, A. E., Marras, T. K., Flume, P. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1318oc · Cited by 356
Self-citationMicrobiological Features and Clinical Relevance of New Species of the Genus Mycobacterium
Tortoli, E. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00035-14 · Cited by 355
Metadata
- Authors
- Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2012-07
- Volume
- 25
- Issue
- 3
- Pages
- 545-582
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2118403978
- Cited by
- 541
- References
- 324
- FWCI
- 19.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.